{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:09:37Z","timestamp":1791223777178,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T00:00:00Z","timestamp":1221523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1750-1172-3-24","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T19:55:46Z","timestamp":1221594946000},"source":"Crossref","is-referenced-by-count":132,"title":["The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK"],"prefix":"10.1186","volume":"3","author":[{"given":"David","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Connock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Wraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,16]]},"reference":[{"key":"124_CR1","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"EF Neufeld","year":"2000","unstructured":"Neufeld EF, Muenzer J: The mucopolysaccharidoses. The metabolic and molecular bases of inherited disease. Edited by: Scriver CR, Sly WS. 2000, New York: McGraw-Hill, 3421-3452."},{"key":"124_CR2","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der PA, Shapiro E, Xue Y: Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics. 2007, 120: e37-e46. 10.1542\/peds.2006-2156.","journal-title":"Pediatrics"},{"key":"124_CR3","doi-asserted-by":"crossref","unstructured":"Connock M, Burls AB, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C: The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease. Health Technol Assess. 2006, 10 (24):","DOI":"10.3310\/hta10240"},{"key":"124_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/bmj.331.7523.1019","volume":"331","author":"A Burls","year":"2005","unstructured":"Burls A, Austin D, Moore D: Commissioning for rare diseases: view from the frontline. BMJ. 2005, 331: 1019-1021. 10.1136\/bmj.331.7523.1019.","journal-title":"BMJ"},{"key":"124_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/bmj.331.7523.1016","volume":"331","author":"C McCabe","year":"2005","unstructured":"McCabe C, Claxton K, Tsuchiya A: Orphan drugs and the NHS: should we value rarity?. BMJ. 2005, 331: 1016-1019. 10.1136\/bmj.331.7523.1016.","journal-title":"BMJ"},{"key":"124_CR6","unstructured":"Human Gene Mutation Database; Institute of Medical Genetics. Cardiff University. Ref Type: Electronic Citation, [\n                    http:\/\/www.hgmd.cf.ac.uk\/ac\/index.php\n                    \n                  ]"},{"key":"124_CR7","unstructured":"Government Actuary Department. Ref Type: Electronic Citation, [\n                    http:\/\/www.gad.gov.uk\/population\/1998\/methodology\/components.asp\n                    \n                  ]"},{"key":"124_CR8","first-page":"221","volume":"284","author":"RB Lowry","year":"1971","unstructured":"Lowry RB, Renwick DH: Relative frequency of the Hurler and Hunter syndromes. New England Journal of Medicine. 1971, 284: 221-222.","journal-title":"New England Journal of Medicine"},{"key":"124_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/BF00206770","volume":"85","author":"RB Lowry","year":"1990","unstructured":"Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY: An update on the frequency of mucopolysaccharide syndromes in British Columbia. Human Genetics. 1990, 85: 389-390. 10.1007\/BF00206770.","journal-title":"Human Genetics"},{"key":"124_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004390050641","volume":"101","author":"J Nelson","year":"1997","unstructured":"Nelson J: Incidence of the mucopolysaccharidoses in Northern Ireland. Human Genetics. 1997, 101: 355-358. 10.1007\/s004390050641.","journal-title":"Human Genetics"},{"key":"124_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.a.20314","volume":"123A","author":"J Nelson","year":"2003","unstructured":"Nelson J, Crowhurst J, Carey B, Greed L: Incidence of the mucopolysaccharidoses in Western Australia. American Journal of Medical Genetics. 2003, 123A: 310-313. 10.1002\/ajmg.a.20314.","journal-title":"American Journal of Medical Genetics"},{"key":"124_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, Van Weely S: The frequency of lysosomal storage diseases in The Netherlands. Human Genetics. 1999, 105: 151-156.","journal-title":"Human Genetics"},{"key":"124_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA. 1999, 281: 249-254. 10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"key":"124_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jmg.35.5.366","volume":"35","author":"AC Hutchesson","year":"1998","unstructured":"Hutchesson AC, Bundey S, Preece MA, Hall SK, Green A: A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet. 1998, 35: 366-370.","journal-title":"J Med Genet"},{"key":"124_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","volume":"28","author":"F Baehner","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C: Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005, 28: 1011-1017. 10.1007\/s10545-005-0112-z.","journal-title":"J Inherit Metab Dis"},{"key":"124_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","volume":"40","author":"JJ Boelens","year":"2007","unstructured":"Boelens JJ, Wynn RF, O'Meara A, Veys P, Bertrand Y, Souillet G: Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant. 2007, 40: 225-233. 10.1038\/sj.bmt.1705718.","journal-title":"Bone Marrow Transplant"},{"key":"124_CR17","unstructured":"National Institute for Health and Clinical Excellence: Appraising orphan drugs. Ref Type: Electronic Citation, [\n                    http:\/\/www.nice.org.uk\/aboutnice\/whoweare\/seniormanagementteam\/seniormanagementteammeetings\/2005\/12july2005\/appraising_orphan_drugs.jsp\n                    \n                  ]"},{"key":"124_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","volume":"91","author":"GM Pastores","year":"2007","unstructured":"Pastores GM, Arn P, Beck M, Clarke JT, Guffon N, Kaplan P: The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I. Mol Genet Metab. 2007, 91: 37-47. 10.1016\/j.ymgme.2007.01.011.","journal-title":"Mol Genet Metab"},{"key":"124_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1001\/archinte.166.18.1938","volume":"166","author":"CD Furberg","year":"2006","unstructured":"Furberg CD, Levin AA, Gross PA, Shapiro RS, Strom BL: The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med. 2006, 166: 1938-1942. 10.1001\/archinte.166.18.1938.","journal-title":"Arch Intern Med"},{"key":"124_CR20","unstructured":"Society for Mucopolysaccharide diseases. Ref Type: Electronic Citation, [\n                    http:\/\/www.mpssociety.co.uk\/\n                    \n                  ]"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-3-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-3-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-3-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T02:23:49Z","timestamp":1548210229000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-3-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,16]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-3-24","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,16]]},"article-number":"24"}}